Buying vs. Leasing a Veterinary ECG With Telecardiology: A Decision Guide for Practices

Choosing between buying a veterinary ECG and leasing one with telecardiology included comes down to four objective criteria, not the device price in isolation: who will read the tracing (an in-house cardiologist or a remote report via telecardiology), monthly exam volume, how many leads the practice needs (6 for screening, 12 for a full workup) and how the exam must flow through to the report. As a rule, buying makes sense for practices that already have their own interpretation capability and a high, steady volume, turning an upfront investment into a very low per-exam cost. Leasing with telecardiology tends to fit low-to-medium-volume practices without a cardiologist on staff, who prefer to trade investment for a predictable recurring cost and have the report signed by a remote specialist. In Brazil, any remote report falls under telediagnosis regulated by CFMV Resolution No. 1.465/2022 and must be issued by a veterinarian with active registration in the CFMV/CRMV system; equivalent rules apply in other jurisdictions.

Upfront investment or recurring cost: what changes in your cash flow

Buying concentrates the spend up front; afterwards the per-exam cost tends to fall as the equipment is amortized. The device becomes a clinic asset, but responsibility for maintenance, calibration, software updates and accessory replacement is now yours. Leasing reverses this logic: the equipment stays with the supplier, and the practice pays a recurring amount, usually tied to a package that already includes the telecardiology report and maintenance. We deal in no figures here, which live outside the institutional site; the decision point is the cash profile your practice can sustain, not the number.

A practical test: estimate how many months you would use the device intensively before a meaningful technology refresh. High volume and a long horizon favor buying, because they spread the investment. Irregular or seasonal volume, or an operation still validating demand for cardiology, favor leasing, which avoids tying up capital in an underused asset and shifts obsolescence risk to the supplier.

Who reads the tracing: in-house cardiologist or telecardiology

This is the criterion that most often settles the model. If the practice has a veterinary cardiologist on staff or accessible specialist cover, buying the device and reading in-house tends to be more coherent: you control turnaround time and depend on no one else. If that expertise is not in-house, telecardiology stops being a convenience and becomes the essential clinical component, because it delivers the specialist interpretation the practice cannot produce on its own.

Telecardiology is already described in the veterinary literature as viable for remote interpretation. In a home-monitoring study using a single-lead ECG sent for remote analysis, 89% of the tracings received were deemed interpretable and there was perfect inter-observer agreement on rhythm diagnosis (Vezzosi et al., 2018). The message for the purchase decision is twofold: telecardiology works, but its quality depends on the quality of the captured signal, which underlines the importance of the equipment and of training whoever records. In Brazil this remote report is regulated telediagnosis and requires a veterinarian with active CFMV/CRMV registration and, when data are shared, an owner consent form (CFMV Resolution No. 1.465/2022).

6 or 12 leads: screening versus full workup

The number of leads defines what the exam can answer. A few-lead recording, or even lead II alone, already lets you assess heart rate and rhythm and detect many arrhythmias, making it suitable for quick deskside screening and follow-up. A study in dogs showed that intervals such as P, QRS and P+QRS are consistent across different devices and positions, which supports the use of simplified recordings for this purpose (Hertzer et al., 2022).

When the goal is a fuller morphological workup, electrical axis, chamber-enlargement patterns and subtle conduction changes, interpretation benefits from multiple simultaneous leads, and the reference standard remains the 12-lead recording. For intermittent arrhythmias, no in-clinic option replaces prolonged monitoring: veterinary cardiology guidelines recommend Holter, for example, in screening for occult dilated cardiomyopathy in Dobermans (Wess et al., 2017). The purchase decision should start from the practice's typical case: if day-to-day work is pre-anesthetic and geriatric screening, 6 leads handle most of it; if the practice receives referrals and complex cases, prioritizing 12 leads or a setup that can scale is worthwhile.

From exam to report: the workflow matters as much as the device

Buying a device and then juggling loose files, manual e-mail sending and a standalone PDF report solves capture but not the workflow. A well-designed leasing model usually delivers the whole path: the exam is recorded, uploaded to the cloud, reaches the specialist and comes back as a signed report within the same environment, with patient history preserved. This chaining cuts rework, lost exams and slow turnaround, which are precisely the pain points that stall cardiology in general-practice routines.

So the right question is not only whether to buy or lease the hardware, but which model delivers the workflow your team can sustain. Platforms such as INpulse One and INcloud exist to integrate capture, storage and telecardiology in one place; the device, bought or leased, is the endpoint of that flow. Assess integration, traceability and report turnaround with the same rigor you apply to lead count.

How to decide, in short

To close, align the criteria with your operation's real profile. Buying tends to fit a practice with its own cardiologist, high and steady volume, frequent need for 12 leads and a long usage horizon, that prefers owning the asset and the lowest possible per-exam cost. Leasing with telecardiology tends to fit a practice without a cardiologist on staff, with low-to-medium or still-unproven volume, that values a remote specialist report, an integrated workflow and a predictable recurring cost, without tying up capital.

Neither model is better in the abstract; the best one is the one your routine can sustain without compromising report quality. The decision is clinical and managerial at once and rests with the responsible veterinarian, who is accountable for interpretation and, in the case of telediagnosis, for the requirements of CFMV Resolution No. 1.465/2022. Use the five criteria in this guide, investment versus recurring cost, who interprets, lead count, workflow to the report, and volume, as a checklist before you commit.